Is there a rationale for combined TNF and IL-1 blocking in arthritis?

Clinical and Experimental Rheumatology

Volumn 20, Issue 5 SUPPL. 27, 2002, Pages

  van den Berg, W B ^a  

^a NONE   (Netherlands)

Author keywords

Cartilage destruction; Experimental arthritis; IL 1; TNF

Indexed keywords

AUTOANTIGEN; CYTOKINE; CYTOKINE ANTIBODY; FREUND ADJUVANT; GLUCOSE 6 PHOSPHATE ISOMERASE; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; METHOTREXATE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; ARTHROPATHY; ARTICLE; CELL STIMULATION; CHRONIC ARTHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENCEPHALOMYELITIS; HUMAN; IMMUNE SYSTEM; MACROPHAGE ACTIVATION; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; RHEUMATOID ARTHRITIS; RODENT; T LYMPHOCYTE;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS; DRUG THERAPY, COMBINATION; HUMANS; INTERLEUKIN-1; MICE; MODELS, ANIMAL; NEOPLASM PROTEINS; RATS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036400156     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. VAN DEN BERG WB: Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res 2001; 3: 18-26.
2. VAN DEN BERG WB: Lessons from animal models of arthritis. Current Rheumatology Reports 2002; 4: 232-9.
3. VAN DEN BERG WB: What we learn from arthritis models to benefit arthritis patients. Ballieres Clin Rheumatol 2000; 14: 599-616.
4. KEFFER J, PROBERT L, CAZLARIS H et al.: Transgenic mice expressing human TNFα: A predictive model of arthritis. EMBO J 1991; 13: 4025-31.
5. PROBERT L, PLOWS D, KONTOGEORGEOS G, KOLLIAS G: The type I IL-1 receptor acts in series with TNFα to induce arthritis in TNFα transgenic mice. Eur J Immunol 1995; 25: 1794-7.
6. VAN DE LOO AAJ, VAN DEN BERG WB: Effects of murine recombinant IL-1 on synovial joints in mice: Measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990; 49: 238-45.
7. HENDERSON B, PETTIPHER ER: Arthrtogenic actions of recombinant IL-1 and TNF in the rabbit: Evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989; 75: 306-10
8. WILLIAMS RO, FELDMANN M, MAINI RN: Anti-TNF ameliorates joint disease in murine collagen-induced arthritis. Proc Nat Acad Sc USA 1992; 89: 9784-8.
9. JOOSTEN LAB, HELSEN MMA, VAN DE LOO FAJ, VAN DEN BERG WB: Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: A comparative study using anti-TNFI, anti-IL-1I/β, and IL-1ra. Arthritis Rheum 1996; 39: 797-809.
10. MORI L, ISELIN S, DE LIBERO, G, LESS-LAUER W: Attenuation of collagen induced arthritis in 55 kDa TNF receptor type I (TNFR) IgG1 treated and TNFR1 deficient mice. J Immunol 1996; 157: 3178-82.
11. CAMPBELL IK, O'DONNEL K, LAWLOR KE, WICKS IP: Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest 2001; 107: 1519-27.
12. SAIJO S, ASANO M, HORAI R, YAMAMOTO H, IWAKURA Y: Suppression of autoimmune arthritis in IL-1 deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. Arthritis Rheum 2002; 46: 533-44.
13. VAN LENT PLEM, VAN DEN LOO FAJ, HOLT-HUYSEN AEM, VAN DEN BERSSELAAR LAM, VERMEER H, VAN DEN BERG WB: Major role for IL-1 but not for TNF in early cartilage damage in immune complex arthritis in mice. J Rheumatol 1995; 22: 2250-8.
14. JI H, PETTIT A, OHMURA K et al.: Critical role for IL-1 and TNFα in antibody induced arthritis. J Exp Med 2002; 196: 77-85.
15. VAN LENT PLEM, NABBE K, BLOM A et al.: Role of activatory Fcgamma R1 and Fc gamma RIII and inhibitory Fc gamma RII in inflammation and cartilage destruction during experimental antigen induced arthritis. Am J Pathol 2001; 159: 2309-20.
16. JI H, OHMURA K, MAHMOOD U et al.: Arthritis critically dependent on innate immune system players. Immunity 2002; 16: 157-68.
17. DENG GM, TARKOWSKI A: Synovial cytokine mRNA expression during arthritis triggerd by CpG motifs of bacterial DNA. Arthritis Res 2001; 3: 48-53.
18. KUIPER S, JOOSTEN LAB, BENDELE AM et al.: Different roles of TNFI and IL-1 in murine streptococcal cell wall arthritis. Cytokine 1998; 10: 690-702.
19. VAN DEN BERG WB, JOOSTEN LAB, KOLLIAS G, VAN DEN LOO FAJ: Role of TNFI in experimental arthritis: Separate activity of IL-1β in chronicity and cartilage destruction. Ann Rheum Dis 1999; 58 (Suppl. I): S140-8.
20. VAN DEN BERG WB, JOOSTEN LAB, VAN DE LOO FAJ: TNFα and IL-1β are separate targets in chronic arthritis. Clin Exp Rheumatol 1999; 17(Suppl. 18): S105-S114.
21. VAN DE LOO AAJ, JOOSTEN LAB, VAN LENT PLEM, ARNTZ OJ, VAN DEN BERG WB: Role of Interleukin-1, Tumor Necrosis Factor I and Interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ cytokine blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995; 38: 164-72.
22. VAN DE LOO AAJ, ARNTZ OJ, BAKKER AC, VAN LENT PLEM, MJM JACOBS, VAN DEN BERG WB: Role of Interleukin-1 in antigen-induced exacerbations of murine arthritis. Am J Pathol 1995; 146: 239-49.
23. BENDELE AM, CHLIPALA ES, SCHERRER J et al.: Combination benefit of treatment with the cytokine inhibitors IL-1Ra and pegylated soluble TNF receptor type I in animal models of rheumatoid arthritis. Arthritis Rheum 2000; 43: 2648-59.
24. FEIGE U, HU YL, GASSER J, CAMPAGNUOLO G, MUNYAKAZI L, BOLON B: Anti-IL-1 and anti-TNFα synergistically inhibit adjuvant arthritis in lewis rats. Cell Mol Life Sci 2000; 57: 1457-70.
25. KASSIOTIS G, KOLLIAS G: Uncoupling the proinflammatory from the immunossuppressive properties of TNF at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J Exp Med 2001; 193: 427-34.
26. HORAI R, SAIJO S, TANIOKA H et al.: Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in 1L-1Ra-deficient mice. J Exp Med 2000; 191: 313-320.
27. NIKI Y, YAMADA H, SEKI S et al.: Macrophage and neutrophil-dominant arthritis in human IL-1α transgenic mice. J Clin Invest 2001; 107: 1127-35.